News About: Pharm. Industry
KOSDAQ-listed firms grapple with falling profits
The combined sales revenue of the 14 KOSDAQ-listed pharmaceutical firms last year marked a growth rate of 8 percent to 431.3 billion won, up 8.3 percent compared with 398.0 billion won from a year earlier but their op...
Competition will heat up in amlodipine market
The domestic amlodipine market is expected to emerge as an arena of fierce competition between domestic and foreign-invested firms from next year, market sources said recently.
Whanin Pharm, a local drug maker, unv...
Foreign drug companies created 370 MW of sales per capita.
Yakup Press unveiled in its survey that 22 foreign multinational drug corporations in Korea have achieved 370 million won of sales per capita in 2003 (an average employee of 269.32/company), which was 1.6 times more t...
Pharmaceutical imports soar 44% in February
Korea's pharmaceutical imports soared 44 percent in February compared with the same month from a year earlier, according to statistics from the National Statistical Office.
Pharmaceutical business sources s...
Samchundang Pharm to induce nifedipine sustained-release formulation technology
Samchundang Pharm said on April 6 that it will induce nifedipine sustained-release formulation technology under a contract with the Korea Research Institute of Chemical and Technology.
Under the contract, Samchunda...
Drug sales per capita at 223,900 thousand won.
The pharmaceutical sales per capita in 2003 unveiled 223,900 thousand won and Green Cross Sang-A recorded the top rank at 427,700 thousand won in the pharmaceutical industry.
The rate of per capita sales growth was...
Health ministry vows to revamp drug-related administration
The Ministry of Health and Welfare says it is contemplating a series of new measures designed to ameliorate pharmaceutical-related regulations. To that end, the ministry plans to revise relevant provisions stipulated ...
Government urged to recruit more BT experts
In situation where Korea has a scanty human resource eligible for assessing the safety and efficacy of new biological products, there is an urgent need to augment the number of eligible experts in the domestic biotech...
Aspartame granular, biggest export drug in 2003
Aspartame granular was the biggest export item in 2003, a private-run trade agency said recently.
The Korea Pharmaceutical Traders Association said that aspartame granular accounted for $19 million, while Gelatine ...
Listed drug companies recorded worst management in 2003.
A protracted business recession had deteriorated overall business management in the pharmaceutical industries, requiring in one way or the other the pharmaceutical business activating measures.
In addition, excessi...
